Cristers
Private Company
Funding information not available
Overview
Cristers is a commercial-stage, privately-held generic drug company founded in 1990 and based in Lyon, France. Its unique ownership structure by the Welcoop pharmacy cooperative aligns its mission with supporting independent French community pharmacies, ensuring drug access nationwide. The company commercializes over 420 presentations (approx. 160 molecules), distributing more than 11 million boxes annually, with manufacturing primarily based in France and Europe. Cristers operates as a fully integrated generics firm, holding its own Marketing Authorizations (AMMs) and launching around 30 new references per year.
Technology Platform
Integrated generics model: Marketing Authorization Holder (MAH) managing regulatory dossiers and bioequivalence studies, with a European-centric GMP manufacturing network.
Opportunities
Risk Factors
Competitive Landscape
Competes against large multinational generics firms (e.g., Teva, Sandoz, Viatris) and other French generics companies. Its key differentiator is ownership by pharmacy cooperative Welcoop, creating a vertically-aligned, loyal customer base insulated from pure price competition.